Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
G.R.V. Hughes.
Thrombosis, abortion, cerebral disease and the lupus anticoagulant.
Br Med J, 287 (1983), pp. 1088-1089
[2.]
The antiphospholipid syndrome II-Autoimmune Thrombosis,
[3.]
W.A. Wilson, A.E. Gharavi, T. Koike, et al.
International Consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop.
Arthritis Rheum, 42 (1999), pp. 1309-1311
[4.]
R.A. Asherson, R. Cervera, P.G. De Groot, et al.
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines.
Lupus, 12 (2003), pp. 530-534
[5.]
Miyakis S, Lockshin MD, Atsumi T, et al. Summary of the international consensus statement on an update of the preliminary classification criteria for antiphospholipid syndrome (APS). J J Thromb Haemostas. En prensa 2005.
[6.]
R. Cervera, M.A. Khamashta, J. Font, et al.
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients.
Medicine (Baltimore), 72 (1993), pp. 113-124
[7.]
J. Balasch, J. Font, A. López-Soto, et al.
Antiphospholipid antibodies in unselected patients with repeated abortion.
Hum Reprod, 5 (1990), pp. 43-46
[8.]
R. Cervera, J.C. Piette, J. Font, et al.
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Arthritis Rheum, 46 (2002), pp. 1019-1027
[9.]
R.A. Asherson.
The catastrophic antiphospholipid antibody syndrome [editorial].
J Rheumatol, 19 (1992), pp. 508-512
[10.]
R.A. Asherson, R. Cervera, J.C. Piette, et al.
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients.
Medicine (Baltimore), 77 (1998), pp. 195-207
[11.]
R.A. Asherson, R. Cervera, J.C. Piette, et al.
Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients.
Medicine (Baltimore), 80 (2001), pp. 355-376
[12.]
D. Alarcón-Segovia, M.C. Boffa, W. Branch, et al.
Prophylaxis of the antiphospholipid syndrome: a consensus report.
Lupus, 12 (2003), pp. 499-503
[13.]
P.L. Meroni, M. Moia, R.H.W.M. Derksen, et al.
Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.
Lupus, 12 (2003), pp. 504-507
[14.]
R.L. Brey, J. Chapman, S.R. Levine, et al.
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002.
Lupus, 12 (2003), pp. 508-513
[15.]
J. Chapman, J.H. Rand, R.L. Brey, et al.
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.
Lupus, 12 (2003), pp. 514-517
[16.]
M. Lockshin, F. Tenedios, M. Petri, et al.
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.
Lupus, 12 (2003), pp. 518-523
[17.]
A. Tincani, W. Branch, R.A. Levy, et al.
Treatment of pregnant patients with antiphospholipid syndrome.
Lupus, 12 (2003), pp. 524-529
[18.]
M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, G.R.V. Hughes.
The management of thrombosis in the antiphospholipid antibody syndrome.
N Engl J Med, 332 (1995), pp. 993-997
[19.]
M.A. Crowther, J.S. Ginsberg, J. Julian, et al.
A comparison of two intensities of warfarin in the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome.
N Engl J Med, 349 (2003), pp. 1133-1138
[20.]
F. Carmona, J. Font, M. Azulay, et al.
Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis.
Am J Reprod Immunol, 46 (2001), pp. 274-279
[21.]
M. Blank, R.A. Asherson, R. Cervera, Y. Shoenfeld.
Antiphospholipid syndrome infectious origin.
J Clin Immunol, 24 (2004), pp. 12-23
Copyright © 2005. Elsevier España S.L. Barcelona
